CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The effects of low-dose radiation therapy in patients with mild-to-moderate Alzheimer's dementia: an interim analysis of a pilot study
Aryun Kim, Jeonghwan Lee, Hansol Moon, Chulhan Kim, Min Young Yoo, Woo Yoon Park, Won Dong Kim, Young-Seok Seo
Radiation Oncology Journal. 2023;41(2):89-97.   Published online 2023 June 26    DOI: https://doi.org/10.3857/roj.2023.00052

Excel Download

The effects of low-dose radiation therapy in patients with mild-to-moderate Alzheimer's dementia: an interim analysis of a pilot study
Radiation Oncology Journal. 2023;41(2):89-97   Crossref logo
Link1 Link2 Link3

P2–409: A pilot study investigating the effects of rosiglitazone on performance in neuropsychological tests in patients with mild–to–moderate Alzheimer's disease
Alzheimer's & Dementia. 2006;2(3S_Part_12):   Crossref logo
Link1 Link2 Link3 Link4 Link5 Link6

P1‐060: THE EFFECTS OF DL‐3‐N‐BUTYLPHTHALIDE IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE ALREADY RECEIVING DONEPEZIL: A MULTICENTER, PROSPECTIVE COHORT STUDY
Alzheimer's & Dementia. 2019;15(7S_Part_5):   Crossref logo
Link1 Link2 Link3 Link4

Vafidemstat in mild to moderate Alzheimer’s disease: The ETHERAL study European cohort interim analysis
Alzheimer's & Dementia. 2020;16(S6):   Crossref logo
Link1 Link2

P4‐230: Acceptability, safety and feasibility of aerobic exercise in patients with mild‐to‐moderate ALZHEIMER'S disease: A pilot study
Alzheimer's & Dementia. 2012;8(4S_Part_19):   Crossref logo
Link1 Link2 Link3 Link4 Link5 Link6

O4‐12‐04: EVP‐6124, a selective alpha‐7 partial agonist, has positive effects on cognition and clinical function in mild‐to‐moderate Alzheimer's disease patients: Results of a six‐month, double‐blind, placebo controlled, dose ranging study
Alzheimer's & Dementia. 2012;8(4S_Part_20):   Crossref logo
Link1 Link2 Link3 Link4 Link5 Link6

[P4–572]: INTERIM REPORT OF A PHASE 2 PILOT SAFETY AND EFFICACY TRIAL OF GM‐CSF/LEUKINE® IN MILD‐TO‐MODERATE ALZHEIMER'S DISEASE
Alzheimer's & Dementia. 2017;13(7S_Part_32):   Crossref logo
Link1 Link2 Link3 Link4 Link5

O1‐04‐04: A multicenter, double‐blind, placebo‐controlled phase IIb proof‐of‐concept dose‐ranging study of AZD3480 and donepezil over 12 weeks in patients with mild to moderate Alzheimer's disease
Alzheimer's & Dementia. 2009;5(4S_Part_3):   Crossref logo
Link1 Link2 Link3 Link4 Link5 Link6

P4‐390: Rapid Onset of Cognitive Improvements in a Subset of Mild and Moderate Alzheimer’S Patients Treated with T3D‐959: Interim Results of a Phase 2A Open Label Clinical Trial
Alzheimer's & Dementia. 2016;12(7S_Part_24):   Crossref logo
Link1 Link2 Link3 Link4 Link5 Link6

P2‐372: Neuropsychological therapy and music geragogy for patients with mild‐to‐moderate dementia
Alzheimer's & Dementia. 2012;8(4S_Part_11):   Crossref logo
Link1 Link2 Link3 Link4 Link5 Link6

This metadata service is kindly provided by CrossRef from May 29, 2014. Radiat Oncol J has participated in CrossRef Text and Data Mining service since October 29, 2014.